The new strain of cannabis that could help treat psychosis

Although widely seen as a potential trigger for schizophrenia, marijuana also contains an ingredient that appears to have antipsychotic effects
The Observer (UK)
Sunday, November 16, 2014

Dr David Potter and GW Pharmaceuticals – a company that is exploring how cannabis could help treat a range of illnesses ranging from epilepsy to cancer – have turned their attention to developing a cannabis-based treatment for psychosis and related illnesses such as schizophrenia. For a drug that is widely seen as a trigger for acute psychotic illness in young users, this at first sounds preposterous. But, as Potter explains, the cannabis plant is much more than just a psychedelic weed. A cannabinoid known as CBD (or cannabidiol) appears to have almost the exact opposite effect.